AI pathology firm Proscia nets $37M investment

14th June 2022 – Contribution by Steve Holloway – Featured on Beckers Hospital Review – Proscia, a company that uses artificial intelligence to treat and research cancer, has raised $37 million in series C funding.

Founded in 2014, the data-driven software developer uses digital images rather than microscopes to advance precision medicine and pathology in the oncology field. The company said the funding will help scale its commercial operations, grow its distribution partnerships and expand its sales, marketing and support teams.